MAPT and early-onset autosomal dominant Alzheimer disease: <h4>Introduction</h4>Plasma phosphorylated tau at threonine 217 (p-tau217) has shown excellent diagnostic performance for Alzheimer's disease (AD), yet real-world validation and implementation pathways remain limited.